‘Barcodes’ in the DNA could prevent disease and slow down ageing, researchers say

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists have discovered “barcodes” within DNA that reveal how blood ages, potentially paving the way for preventing age-related illnesses like blood cancer and heart disease before symptoms emerge.

The research, published in the journal Nature, also suggests the possibility of developing therapies to slow or even reverse the ageing process.

The study pinpointed specific stem cells, referred to as “clones,” that progressively dominate blood production as individuals age, typically between 50 and 60.

These clones preferentially generate myeloid cells, a type of immune cell associated with chronic inflammation. This shift in blood cell production could be a key factor in the development of age-related diseases.

In younger individuals, a diverse pool of 50,000 to 200,000 stem cells is responsible for replenishing a staggering 100 billion to 200 billion blood cells daily.

The discovery of these DNA “barcodes” offers a new understanding of how this intricate system evolves over time and how age-related changes might contribute to disease.

Scientists have discovered “barcodes” within DNA (Getty/iStock)

“As we age, some of these stem cells disappear and their function needs to be taken over by others, which then expand,” said Dr Lars Velten, group leader at the Centre for Genomic Regulation (CRG) in Barcelona.

“And by the age of 50 or 60, we get these clones. This is a group of cells that stem from the same mother stem cell.

“And these clones are important because they are first step in leukaemia formation, and they also contribute to inflammation, because the blood cells that derive from them are emitting molecules that fuel the inflammation process, and therefore there’s also this link to heart disease risk.”

According to Dr Velten, tracking every blood cell back to its original stem cell has been possible only in animal research.

His team looked at changes in the chemical tags, known as methylation marks, attached to DNA.

Theses tags help cells know which genes to switch on and off, and when a stem cell divides, methylation marks are copied to its daughter cells.

“This is sort of like having a unique barcode for every cell when we’re young, and then this barcode identifies all the descendants, all the children and grandchildren and great-grandchildren, of these cells as we age,” Dr Velten added.

Scientists have developed a technique to read “barcodes” in the DNA (PA) (PA Archive)

To read these “barcodes”, scientists developed a technique known as EPI-Clone.

They used it to reconstruct the history of blood production in both mice and humans, tracing which stem cells contributed to making blood.

In older mice, EPI-Clone showed that blood stem cells comprised just a few dozen large clones.

The pattern was also found in humans, with larger clones taking over blood production from age 50.

This discovery could one day allow doctors to look at how a patient’s blood is ageing, potentially years before diseases develop, researchers suggested.

Dr Alejo Rodriguez-Fraticelli, also group leader at IRB Barcelona, said: “The idea is that this could be an early intervention tool for cancers, starting with blood cancers, where we know that expansions in these stem cells identify individuals that are at risk of developing blood malignancies.”

The study also found many of the dominant clones produced myeloid cells, which are linked to chronic inflammation.

Research using mice has shown removing these particular clones can rejuvenate blood stem cells.

Researchers are hopeful the tool could pave the way for the exploration of rejuvenation therapies in humans as it allows for scientists to pinpoint problematic clones.

Dr Rodriguez-Fraticelli added: “If we target the expanded clones, there may be the hope that we may ablate them and then let the diversity of the hematopoietic system, the blood regeneration system, really rejuvenate.”

Dr Velten said: “If we want to move beyond generic anti-ageing treatments and into real precision medicine for ageing, this is exactly the kind of tool we need.

“We can’t fix what we can’t see and for the first time, EPI-Clone can facilitate this for humans.”